Arquivamento - Art. 36 §1° da LPI
#11.2
10/13/2020
RPI 2597
Application data
Number
122017026628Type
Filing
Publication
PCT
US2014069853 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/13/2020. We update with every new RPI gazette, published weekly.
Applicants
BIOGEN MA INC.
US
SUNESIS PHARMACEUTICALS, INC.
US
Inventors
No inventors listed.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
10/13/2020
RPI 2597
#6.21
06/16/2020
RPI 2580
#7.5
04/28/2020
RPI 2573
#25.7
01/14/2020
RPI 2558
#25.1
12/31/2019
RPI 2556
#7.4
De acordo com o artigo 229-C da Lei nº 10196/2001, que modificou a Lei nº 9279/96, a concessão da patente está condicionada à anuência prévia da ANVISA. Considerando a aprovação dos termos do Parecer nº 337/PGF/EA/2010, bem como a Portaria Interministerial Nº 1065 de 24/05/2012, encaminha-se o presente pedido para as providências cabíveis.
05/02/2018
RPI 2469
#2.4
Dividido do PCT 11 2016 012860-5
01/09/2018
RPI 2453
#2.5
Dividido do PCT 11 2016 012860-5
12/26/2017
RPI 2451
#2.10
Protocolo nº 870170096487, em 11/12/2017; 13:09 (WB); Dividido do PCT BR 11 2016 012860-5
12/19/2017
RPI 2450
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.